PODCAST: U.S.-Canada Trade Relations – What Corporations Need to Know — C&M's First 100 Days Series
Client Alert | 1 min read | 02.24.17
In the latest podcast for Crowell & Moring's "First 100 Days" series, Jim Flood, chair of the firm's Government Affairs Group, sits down with Ian Laird, co-chair of the firm's International Dispute Resolution Group, to discuss the state of U.S.-Canada trade relations. Ian is a Canadian-qualified lawyer and previously served as chief of staff to a Canadian cabinet minister, as well as a senior political aide to the Ontario Minister of Energy. Ian represents companies engaged in U.S.-Canada trade and business relations and has provided counsel on NAFTA issues for more than 15 years. Ian also worked on the earliest NAFTA investor-state arbitrations involving each of the three NAFTA state parties.
Discussed in this 20 minute podcast recorded on Feb. 17:
- Some potential strategies for the Canadian Government and Canadian companies to succeed in working with the Trump Administration.
- Potential “tweaks” to NAFTA with respect to Canada, and redefining U.S.-Canada relations.
- Views of the Republican-controlled U.S. House of Representatives, and a different approach from the U.S. Senate.
- How Canada's immigration policies might impact business.
- Potential timeline for any changes, and what companies can do now.
Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes
Insights
Client Alert | 8 min read | 06.30.25
AI Companies Prevail in Path-Breaking Decisions on Fair Use
Last week, artificial intelligence companies won two significant copyright infringement lawsuits brought by copyright holders, marking an important milestone in the development of the law around AI. These decisions – Bartz v. Anthropic and Kadrey v. Meta (decided on June 23 and 25, 2025, respectively), along with a February 2025 decision in Thomson Reuters v. ROSS Intelligence – suggest that AI companies have plausible defenses to the intellectual property claims that have dogged them since generative AI technologies became widely available several years ago. Whether AI companies can, in all cases, successfully assert that their use of copyrighted content is “fair” will depend on their circumstances and further development of the law by the courts and Congress.
Client Alert | 3 min read | 06.30.25
Client Alert | 3 min read | 06.26.25
FDA Targets Gene Editing Clinical Trials in China and other “Hostile Countries”
Client Alert | 3 min read | 06.26.25
